Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL380P (RNA, 7SL, cytoplasmic 380, pseudogene) is classified as a pseudogene that is homologous to the 7SL RNA gene, with no evidence of encoding a functional product or exerting direct biological activity[1][5][8]. The human genome contains hundreds of 7SL pseudogenes, which are believed to originate through reverse transcription of mature 7SL RNA and reintegration into the genome[5][8]. These sequences are typically truncated and do not produce a functional 7SL RNA, which normally serves as the essential RNA component of the signal recognition particle complex required for cotranslational targeting of proteins to the endoplasmic reticulum[7]. The pseudogene class (including RN7SL380P) generally does not encode proteins and is not considered a therapeutic target or associated with specific diseases[6]. There is no evidence to suggest that RN7SL380P has any established biomarker, drug interactions, or clinical utility. Note: - This entry is primarily a processed pseudogene, not a protein-coding gene or known regulatory RNA. - There is no described receptor, enzyme, transporter, or signaling function. - "is_incorrect" is set to true because pseudogenes like RN7SL380P are generally not considered valid therapeutic targets or functional molecules in the sense typically meant in drug discovery[1][6][8]. - The small body of research suggests some pseudogenes can have regulatory non-coding RNA functions in specific contexts, but there is no indication that RN7SL380P itself does[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 380, pseudogene (RN7SL380P).